A First-in-Human Single and Multiple Ascending Dose Study of MT-251

Clinical trial NCT07423299 · RECRUITING

Trial details

NCT number: NCT07423299
Sponsor: Mirador Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2026-01-23
Primary completion: 2027-03-08
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.